Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate COVID-19-infection”

355 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 355 results

Early research (Phase 1)UnknownNCT05083000
What this trial is testing

Reducing Hypoxia in Patients With Coronavirus Disease (COVID-19) Using Topotecan With Standard of Care

Who this might be right for
COVID-19 Respiratory Infection
National University Hospital, Singapore 24
Not applicableUnknownNCT04429711
What this trial is testing

Ivermectin vs. Placebo for the Treatment of Patients With Mild to Moderate COVID-19

Who this might be right for
COVID-19
Sheba Medical Center 100
Testing effectiveness (Phase 2)Ended earlyNCT05226533
What this trial is testing

Clinical Trials to Assess Safety and Efficacy of DWRX2003 Combination With Remdesivir in Moderate to Severe COVID-19 Patients.

Who this might be right for
COVID-19
Daewoong Pharmaceutical Co. LTD. 1
Early research (Phase 1)Ended earlyNCT05075304
What this trial is testing

A Safety and Tolerability Study of BDB-001 in Mild, Moderate COVID-19 Patients

Who this might be right for
COVID-19
Staidson (Beijing) Biopharmaceuticals Co., Ltd 18
Early research (Phase 1)Ended earlyNCT05429021
What this trial is testing

IMM-BCP-01 in Mild to Moderate COVID-19

Who this might be right for
SARS-CoV2 InfectionCOVID-19
Immunome, Inc. 9
Testing effectiveness (Phase 2)Study completedNCT04561219
What this trial is testing

Nitazoxanide Therapy for Patients With COVID-19 Pneumonia

Who this might be right for
Covid19Corona Virus InfectionPneumonia, Viral
Universidade Federal do Rio de Janeiro 500
Not applicableUnknownNCT05629975
What this trial is testing

Oral Nutritional Supplements in Treatment of Elderly Mild-to-Moderate COVID-19

Who this might be right for
Nutrition, Healthy
Shanghai Tongji Hospital, Tongji University School of Medicine 150
Testing effectiveness (Phase 2)Ended earlyNCT05156671
What this trial is testing

Adrecizumab (HAM8101) to Improve Prognosis and Outcomes in COVID-19 Trial

Who this might be right for
COVID-19
Universitätsklinikum Hamburg-Eppendorf 16
Testing effectiveness (Phase 2)Study completedNCT04709835
What this trial is testing

Study to Evaluate the Effects of AT-527 in Non-Hospitalized Adult Patients With Mild or Moderate COVID-19

Who this might be right for
COVID-19
Hoffmann-La Roche 104
Testing effectiveness (Phase 2)UnknownNCT04472585
What this trial is testing

Efficacy of Subcutaneous Ivermectin With or Without Zinc in COVID-19 Patients

Who this might be right for
Coronavirus InfectionCOVIDSars-CoV2
Sohaib Ashraf 180
Not applicableUnknownNCT05692258
What this trial is testing

Acupuncture as an Adjunctive Therapy for Covid-19 Omicron Randomised Controlled Trial in Patients With Moderate/Severe Pneumonia

Who this might be right for
AcupunctureCovid-19 OmicronPulmonary Function
The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine 146
Testing effectiveness (Phase 2)Looking for participantsNCT04896606
What this trial is testing

SARS-CoV-2 CTLS for Mild to Moderate COVID-19 Disease

Who this might be right for
Covid19
New York Medical College 50
Large-scale testing (Phase 3)Study completedNCT05084911
What this trial is testing

The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients (Phase3)

Who this might be right for
COVID-19
Shin Poong Pharmaceutical Co. Ltd. 1,807
Large-scale testing (Phase 3)WithdrawnNCT05552625
What this trial is testing

The Efficacy and Safety of TADIOS as an Adjuvant Therapy in Patients Diagnosed With Mild to Moderate COVID-19

Who this might be right for
COVID-19
Helixmith Co., Ltd.
Not applicableUnknownNCT05165979
What this trial is testing

Cohort Study for the Assessment of Long-term Impact of COVID-19 Among Moderate and Severe COVID-19 Patients in Brazil

Who this might be right for
COVID-19Quality of LifeDisability Physical+1 more
Hospital Moinhos de Vento 650
Very early researchTemporarily pausedNCT04329572
What this trial is testing

Efficacy and Safety of Hydroxychloroquine and Azithromycin for Patients With Moderate to Severe COVID-19

Who this might be right for
COVID-19
Azidus Brasil 400
Not applicableLooking for participantsNCT06490744
What this trial is testing

Evolution of Respiratory Function in Lung Transplant Patients With Moderate to Severe Covid-19 Infection

Who this might be right for
COVID-19 Respiratory Infection
University Hospital, Strasbourg, France 75
Large-scale testing (Phase 3)Study completedNCT04292730
What this trial is testing

Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment

Who this might be right for
COVID-19
Gilead Sciences 1,113
Testing effectiveness (Phase 2)WithdrawnNCT04797975
What this trial is testing

Off-the-shelf NK Cells (KDS-1000) as Immunotherapy for COVID-19

Who this might be right for
Covid19
Kiadis Pharma
Testing effectiveness (Phase 2)Study completedNCT04524663
What this trial is testing

Oral Camostat Compared With Standard Supportive Care in Mild-Moderate COVID-19 Patients

Who this might be right for
Covid19
Stanford University 49
Load More Results